- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Managed Care Minute: May 2, 2015
A one-minute look at managed care news during the week of April 27, 2015, including more good news for the much-anticipated PCSK9 inhibitors and growth in the individual insurance market enrollment.
This week, a meta-analysis in JAMA confirmed that the PCSK9 inhibitors dramatically reduce low-density lipoprotein as well as all-cause mortality and cardiovascular mortality. However, an accompanying editorial cautioned against too much enthusiasm.
A new report from the Kaiser Family Foundation found that enrollment in the individual insurance market grew in 2014 after the first open enrollment period of the Affordable Care Act. Enrollment is expected to continue to grow in 2015, but at a slower pace.
The first videos from the Spring 2015 Oncology Stakeholders Summit is now available online here.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
